AptarGroup Division Says It Gets US FDA 510K Clearance for HeroTracker Sense as Class 2 Medical Device

MT Newswires Live
2025/10/16

AptarGroup's (ATR) Aptar Digital Health division said Thursday that its HeroTracker Sense has received the US Food and Drug Administration's 510k clearance as a Class 2 medical device.

HeroTracker Sense is compatible with multiple asthma and chronic obstructive pulmonary disease medicines, and helps patients oversee their respiratory health through medication and symptom management, Aptar Digital said.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10